Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-19 01:06 CEST (UTC+2h)

95% Upper bound calculation [RSABE / ABEL]

posted by GM - India, 2018-03-07 06:25  - Posting: # 18502
Views: 804

Hello All :waving:,

Hope all are doing well...!!!

Do anybody suggest manual calculation of 95% upper bound in RSABE approach....

Actually I am trying to do this for IVPT study analysis using guidance Acyclovir 5% cream. But here the reference treatment was replicated more than 2 times.

Is it possible to follow the RSABE approach as per the Progesterone Guidance..?

Kindly suggest me something relavent to this.

Thankyou in Advance :-).

Regards,
GM

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,384 posts in 3,905 threads, 1,172 registered users;
online 13 (1 registered, 12 guests [including 8 identified bots]).

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed